Experienced in Peripheral T-Cell Lymphoma

Reda Garidi

Saint-quentin-le-verger, FR 
Experienced in Peripheral T-Cell Lymphoma
Saint-quentin-le-verger, FR 
OverviewLocationsClinical Research

Overview

Reda Garidi practices in Saint-quentin-le-verger, France. Ms. Garidi is rated as an Experienced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Febrile Neutropenia, Acute Promyelocytic Leukemia, Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Peripheral T-Cell Lymphoma.

Gender
Female

Locations

Saint-quentin-le-verger, France
Other Locations
Avenue Laënnec Salouël, 80054 Amiens Cedex 1, Amiens, 80054, France
Meaux, France
St. Quentin General Hospital, St. Quentin
Saint-quentin-sur-indrois, France
St Quentin, Sete, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Non-interventional, Multinational Study Evaluating the Efficacy and the Safety of High Dose Therapy Followed by Autologous Hematopoietic Stem Cell Transplantation as a Frontline Therapy for Myeloma Patients With Severe Renal Impairment (IRMYG Study)
A Prospective, Non-interventional, Multinational Study Evaluating the Efficacy and the Safety of High Dose Therapy Followed by Autologous Hematopoietic Stem Cell Transplantation as a Frontline Therapy for Myeloma Patients With Severe Renal Impairment (IRMYG Study)
Enrollment Status: Completed
Publish Date: May 06, 2023
Intervention Type: Other
Randomized Phase III Study Comparing Conventional Chemotherapy to Low Dose Total Body Irradiation-Based Conditioning and HCT From Related and Unrelated Donors as Consolidation Therapy for Older Patients With AML in 1st Complete Remission
Randomized Phase III Study Comparing Conventional Chemotherapy to Low Dose Total Body Irradiation-Based Conditioning and HCT From Related and Unrelated Donors as Consolidation Therapy for Older Patients With AML in 1st Complete Remission
Enrollment Status: Terminated
Publish Date: October 14, 2021
Intervention Type: Drug, Procedure
Study Phase: Phase 3
View 1 Less Clinical Trial

24 Total Publications

[Erratum to "Haematopoietic stem cell transplantation in the treatment of autoimmune diseases" [Rev. Med. Interne 29 (2008) 115-121]].
[Erratum to "Haematopoietic stem cell transplantation in the treatment of autoimmune diseases" [Rev. Med. Interne 29 (2008) 115-121]].
Journal: La Revue de medecine interne
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Garidi's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile